Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock.
Shan P ModiYeahwa HongMcKenzie M SickeNicholas R HessWyatt J KlassLuke A ZieglerRyan M RivosecchiGavin W HickeyDavid J KaczorowskiRaj RamananPublished in: medRxiv : the preprint server for health sciences (2023)
Although ECpella patients that received initial Impella support have higher success in bridging to heart transplant, allcomers on ECpella support should be evaluated for advanced therapies early in their clinical course. Further studies are required to ascertain the differences in pathophysiology between cardiogenic shock secondary to acute myocardial infarction and cardiogenic secondary to acute decompensated heart failure and determine appropriate support strategies for differing cardiogenic shock phenotypes.
Keyphrases
- heart failure
- acute myocardial infarction
- extracorporeal membrane oxygenation
- ejection fraction
- liver failure
- left ventricular
- end stage renal disease
- respiratory failure
- newly diagnosed
- acute respiratory distress syndrome
- percutaneous coronary intervention
- prognostic factors
- acute coronary syndrome
- drug induced
- left ventricular assist device
- aortic dissection
- cardiac resynchronization therapy
- intensive care unit
- patient reported